Use of norepinephrine reuptake inhibitors for the treatment...

Details Use of norepinephrine reuptake inhibitors for the treatment... Use of norepinephrine reuptake inhibitors for the treatment...

A - Human Necessities

61

K

A61K 31/00 (2006.01) A61K 31/137 (2006.01) A61K 31/138 (2006.01) A61K 31/5375 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2467802

Selective norepinephrine reuptake inhibitors, particularly atomoxetine, reboxetine and 2-alkylthio substituted phenoxyphenyl propylamines, are used for the treatment of cognitive failure, including cognitive failure due to dementia, delirium and schizophrenia.

L'invention concerne des inhibiteurs de recaptage de la noradrénaline, en particulier des atomoxétine, réboxtine et 2-alkylthio phénoxyphényl propylamines substituées, qui sont utilisés dans le traitement de la défaillance cognitive provoquée par la démence, le délirium et la schizophrénie.

Affiliated with

Also associated with

Rating

Use of norepinephrine reuptake inhibitors for the treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of norepinephrine reuptake inhibitors for the treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of norepinephrine reuptake inhibitors for the treatment... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1471987